As the founder of T.P.I.-Pharm, I am deeply committed to promoting the safety of medications and protecting the well-being of patients. Through our commitment to excellence and innovation in pharmacovigilance, we strive to have a meaningful impact on healthcare by ensuring that every drug meets the highest standards of safety and efficacy.
Jean Sîli, founder of T.P.I.-Pharm
Our Approach to Pharmacovigilance
How do we ensure the safety and effectiveness of medications?
At T.P.I.-Pharm, we embrace our responsibility to ensure the health of patients by providing comprehensive pharmacovigilance services. We use a rigorous approach to effectively monitor, identify and manage any adverse effects related to pharmaceutical products.
This is the process every medicine undergoes before it is distributed to patients:
Planning and Strategy Development
Before we embark on any pharmacovigilance project, we meticulously plan and develop a strategic framework tailored to your specific needs. Our team collaborates with you to define project objectives, scope, and timelines, ensuring alignment with regulatory requirements and industry best practices.Data Collection and Monitoring
We employ advanced data collection methods to gather information from diverse sources, including clinical trials, spontaneous reports, literature, and social media. Our robust monitoring systems allow us to continuously track and analyze adverse events, enabling early detection of potential safety concerns.Adverse Event Detection and Assessment
Our experienced pharmacovigilance experts meticulously review and assess reported adverse events to determine their severity and potential causality. Through rigorous medical evaluation and analysis, we provide valuable insights into the relationship between adverse events and the drugs in question.Reporting and Documentation
Our dedicated team ensures timely and accurate preparation of regulatory reports, including Individual Case Safety Reports (ICSRs), Periodic Safety Update Reports (PSURs), and Development Safety Update Reports (DSURs). We maintain meticulous documentation of all pharmacovigilance activities, providing transparency and accountability.Continuous Improvement and Quality Assurance
At T.P.I.-Pharm, we are committed to ongoing quality improvement and excellence in pharmacovigilance. We conduct regular quality assurance audits to ensure compliance with regulatory requirements and industry standards, while also staying abreast of emerging trends and advancements in drug safety.
Why should you choose us?
Commitment to Quality
We uphold the highest standards of quality in all our operations. Our rigorous quality assurance practices ensure that your products meet regulatory requirements globally.
Expertise and Experience
With a seasoned team of pharmacovigilance experts, we bring years of experience in monitoring, analyzing, and reporting adverse drug reactions.
Comprehensive Solutions
From streamlined adverse event reporting processes to robust risk management strategies, we offer comprehensive pharmacovigilance solutions tailored to your specific needs.
Schedule a visit to our headquarters! We're looking forward to seeing you.
bd. Dacia 58/10, Chișinău, Republic of Moldova
Our Values
Our values are the foundation on which we base the service delivery to our partners. We are guided in our daily work by clear principles, with every decision reflecting our dedication to the health and safety of patients, contributing to the continuous advancement of pharmacovigilance.
Satisfied patients
The pharmacovigilance services were exceptional. The team was prompt and professional, ensuring that all our questions were clearly answered. I greatly appreciated their transparency in managing the safety of medications. I felt well informed throughout the process.
Kristin Watson
Jun 27, 2020
Frequently Asked Questions
What is pharmacovigilance, and why is it important?
Pharmacovigilance is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. It plays a crucial role in monitoring the safety of pharmaceutical products throughout their lifecycle, from clinical trials to post-marketing surveillance. By identifying and assessing adverse events, pharmacovigilance ensures the timely detection and management of potential risks, ultimately contributing to the protection of public health.
How does pharmacovigilance contribute to patient safety?
Pharmacovigilance contributes to patient safety by systematically monitoring, analyzing, and reporting adverse events associated with pharmaceutical products. Through proactive surveillance and assessment of safety data, pharmacovigilance helps identify potential risks early, enabling timely intervention and risk mitigation measures. By ensuring that the benefits of medications outweigh their risks, pharmacovigilance plays a critical role in enhancing patient safety and minimizing harm.
What types of adverse events does pharmacovigilance monitor?
Pharmacovigilance monitors a wide range of adverse events, including but not limited to:
Adverse drug reactions (ADRs)
Medication errors
Drug interactions
Overdoses
Product quality issues
Unexpected therapeutic failures
Off-label use complications
Use during pregnancy or lactation
How are adverse events reported in pharmacovigilance?
Adverse events can be reported through various channels, including healthcare professionals, patients, pharmaceutical companies, regulatory authorities, and literature sources. These reports, known as Individual Case Safety Reports (ICSRs), contain detailed information about the adverse event, including patient demographics, medical history, drug exposure, and description of the event. Pharmacovigilance teams review and analyze these reports to assess the causality and severity of adverse events.
What role does pharmacovigilance play in regulatory compliance?
Pharmacovigilance plays a critical role in regulatory compliance by ensuring that pharmaceutical companies meet the safety monitoring and reporting requirements set forth by regulatory agencies worldwide. Compliance with pharmacovigilance regulations is essential for obtaining and maintaining marketing authorization for pharmaceutical products. Pharmacovigilance activities, such as adverse event reporting, signal detection, and risk management, are integral components of regulatory submissions and post-marketing surveillance obligations.
How does your company ensure data confidentiality and patient privacy in pharmacovigilance?
At our company, we prioritize data confidentiality and patient privacy in all our pharmacovigilance activities. We adhere to strict protocols and regulatory guidelines to safeguard sensitive information throughout the data collection, processing, and reporting processes. Our team undergoes rigorous training on data protection principles, and we implement robust security measures, including encryption, access controls, and secure data storage practices. Additionally, we comply with relevant data protection laws, such as the General Data Protection Regulation (GDPR) and Health Insurance Portability and Accountability Act (HIPAA), to ensure the highest standards of confidentiality and privacy protection.
